亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies

受体 癌症研究 医学 内科学
作者
Jiaxi Wu,Nicolin Bloch,Aaron Y. Chang,Ramandeep Bhavsar,Qingqing Wang,Alison Crawford,David J. DiLillo,Kristin Vazzana,Katja Mohrs,Drew Dudgeon,Supriya Patel,Hassan Shakil Ahmed,Vidur Garg,Michael Amatulli,Olivia Q. Antao,Yuetian Yan,Shunhai Wang,Willy Ramos,Pamela Krueger,Christina Adler
出处
期刊:Cell reports medicine [Elsevier BV]
卷期号:5 (10): 101747-101747 被引量:35
标识
DOI:10.1016/j.xcrm.2024.101747
摘要

The clinical use of interleukin-2 (IL-2) for cancer immunotherapy is limited by severe toxicity. Emerging IL-2 therapies with reduced IL-2 receptor alpha (IL-2Rα) binding aim to mitigate toxicity and regulatory T cell (Treg) expansion but have had limited clinical success. Here, we show that IL-2Rα engagement is critical for the anti-tumor activity of systemic IL-2 therapy. A “non-α” IL-2 mutein induces systemic expansion of CD8 + T cells and natural killer (NK) cells over Tregs but exhibits limited anti-tumor efficacy. We develop a programmed cell death protein 1 (PD-1)-targeted, receptor-masked IL-2 immunocytokine, PD1-IL2Ra-IL2, which attenuates systemic IL-2 activity while maintaining the capacity to engage IL-2Rα on PD-1 + T cells. Mice treated with PD1-IL2Ra-IL2 show no systemic toxicities observed with unmasked IL-2 treatment yet achieve robust tumor growth control. Furthermore, PD1-IL2Ra-IL2 can be effectively combined with other T cell-mediated immunotherapies to enhance anti-tumor responses. These findings highlight the therapeutic potential of PD1-IL2Ra-IL2 as a targeted, receptor-masked, and “α-maintained” IL-2 therapy for cancer. • IL-2Rα engagement is important for the anti-tumor activity of systemic IL-2 therapy • Masked IL-2 is attenuated but retains the ability to engage endogenous IL-2Rα • PD1-IL2Ra-IL2 exhibits PD-1-targeting-dependent IL-2 activity and reduced toxicity • PD1-IL2Ra-IL2 shows potent anti-tumor efficacy alone and in combination therapies The clinical use of IL-2 therapy for cancer is limited by severe toxicity. Wu et al. develop a PD-1-targeted, masked, and “α-maintained” IL-2 immunocytokine, PD1-IL2Ra-IL2, which exhibits minimal systemic IL-2 toxicity while delivering robust anti-tumor efficacy both as a monotherapy and in combination with other immunotherapies in preclinical models.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
醉熏的孤云完成签到,获得积分10
4秒前
852的应助被liuqiwei采纳,获得200
13秒前
19秒前
彩色白竹完成签到,获得积分10
20秒前
20秒前
21秒前
bwx发布了新的文献求助200
21秒前
32秒前
傻傻的含莲完成签到,获得积分10
33秒前
33秒前
37秒前
丘比特的应助被执着念烟采纳,获得10
38秒前
38秒前
38秒前
40秒前
41秒前
41秒前
42秒前
42秒前
43秒前
45秒前
46秒前
46秒前
46秒前
46秒前
47秒前
48秒前
48秒前
49秒前
51秒前
51秒前
53秒前
54秒前
jjj完成签到 ,获得积分10
55秒前
55秒前
55秒前
纯情的阁发布了新的文献求助10
56秒前
56秒前
56秒前
纯情的阁发布了新的文献求助10
56秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158848
求助须知:如何正确求助?哪些是违规求助? 9554492
关于积分的说明 21719333
捐赠科研通 7748419
什么是DOI,文献DOI怎么找? 3427099
关于科研通互助平台的介绍 2552006
邀请新用户注册赠送积分活动 2471370